Liones
15/11/21 20:08
Ha respondido al tema
Novavax (NVAX): Un Nuevo Comienzo
Novavax files for approval of COVID-19 vaccine in South KoreaNov. 15, 2021 9:50 AM ETNovavax, Inc. (NVAX)By: Mamta Mayani, SA News Editor3 Commentspeterschreiber.media/iStock via Getty ImagesNovavax (NVAX +0.6%) and SK bioscience announce the submission of a Biologics License Application (BLA) for NVAX's COVID-19 vaccine to South Korea's Ministry of Food and Drug Safety (MFDS).NVX-CoV2373, Novavax' recombinant nanoparticle COVID-19 vaccine with Matrix-M adjuvant, is the first protein-based COVID-19 vaccine to be submitted for BLA in Korea.SK bio initiated the rolling submission process for NVX-CoV2373 to the MFDS in April of this year.NVAX and SK bio have an existing manufacturing and licensing collaboration that is intended to provide broad and equitable access to NVX-CoV2373 both in Korea and globally through the COVAX Facility.Earlier this month, Novavax filed for provisional approval of its COVID-19 vaccine in New Zealand.https://seekingalpha.com/news/3770691-novavax-files-for-approval-of-covid-19-vaccine-in-south-korea